Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly
2026-09-17
The reference study examines how digitally shaped bottlebrush segments influence phase behavior in ABC coil–bottlebrush triblock terpolymers. Across a library of narrowly distributed polymers, SAXS showed robust segregation but predominantly hexagonal and lamellar morphologies, while the double-gyroid phase was systematically suppressed and ordering remained unexpectedly slow.
-
Praeruptorin A: Mechanism-to-Assay Roadmap
2026-09-17
Praeruptorin A is an angular pyranocoumarin compound with interconnected effects on ferroptosis, inflammation, barrier integrity, metastasis, and myocardial injury. This mechanism-to-assay roadmap explains how to test those effects without confusing pathway association with causality.
-
QX77 Molecular Chaperone Activator Workflows
2026-09-16
QX77 supports targeted investigation of LAMP2A- and Rab11-linked autophagy processes while offering a practical bridge to stem cell differentiation assays. This guide provides an assay-ready workflow, reference-study context, and troubleshooting strategies without overstating its preclinical scope.
-
SB525334: Precision Across the TGF-β1 Axis
2026-09-16
TGF-β1 can drive pathological fibrosis yet support vascularized tissue repair. This thought-leadership article examines how SB525334 enables precise ALK5 pathway interrogation, connects renal and wound-healing models, and helps translational researchers distinguish therapeutic inhibition from context-dependent pathway biology.
-
Machine Learning for Senolytic Discovery
2026-09-15
The 2023 Nature Communications study developed machine-learning models from published senolytic data and used them to identify ginkgetin, periplocin, and oleandrin as active compounds. Its main contribution is methodological: carefully curated, heterogeneous literature data can support substantially lower-cost early drug discovery when computational predictions are paired with cell-based validation.
-
Ceramides Enable RGNNV Replication via Autophagy
2026-09-15
A lipidomics study shows that red-spotted grouper nervous necrosis virus reshapes host sphingolipid metabolism, with ceramide accumulation supporting viral replication. Pharmacological inhibition, knockdown, rescue with C16-ceramide, and autophagy experiments identify ceramide flux as a mechanistically actionable host factor while also defining important limits for translation.
-
Nebivolol hydrochloride: Assay Workflows
2026-09-14
Nebivolol hydrochloride enables selective β1-receptor pathway interrogation while also serving as a useful negative comparator in drug-sensitized yeast mTOR screens. This guide covers solvent handling, concentration-response design, cross-platform controls, and troubleshooting for cardiovascular pharmacology research.
-
Salvianolic Acid B: Reframing Fibrotic Matrix Biology
2026-09-14
Salvianolic acid B is emerging as a mechanism-led research tool for pulmonary fibrosis studies. By connecting LH2 expression, collagen cross-linking, cell-state transitions, and extracellular matrix architecture, this article outlines a practical translational strategy that goes beyond total collagen measurements.
-
3-Deazaadenosine Hydrochloride in Methylation Assays
2026-09-13
3-Deazaadenosine hydrochloride is a selective S-adenosylhomocysteine hydrolase inhibitor for probing methyl-metabolism effects in hepatic stellate cell assays. This guide shows how to use it as a broad biochemical perturbation alongside the IGF2BP1–TUBB4B–FAK pathway without mistaking pathway association for mechanism-specific proof.
-
Doxycycline: Mechanism, Evidence & Research Workflows
2026-09-12
Doxycycline is a tetracycline antibiotic with ribosomal antibacterial activity and research relevance as a metalloproteinase inhibitor. This article separates validated doxycycline properties from cancer-delivery evidence involving other drugs and provides product-specific handling parameters for reproducible experiments.
-
Praeruptorin A in Doxorubicin Cardiomyopathy
2026-09-12
The reference study used a ferrous-ion probe to screen herbal small molecules and identified Praeruptorin A as an inhibitor of DMT1-associated iron accumulation and ferroptosis in doxorubicin-induced cardiomyopathy. Its design links phenotypic Fe²⁺ screening with cellular and mouse validation, while the tumor-combination results suggest a potentially useful separation between cardioprotection and anticancer activity that requires further study.
-
Batimastat (BB-94): MMP Insight for Translation
2026-09-11
Batimastat (BB-94) offers a mechanistically grounded way to interrogate matrix metalloproteinase activity across tumor biology and emerging neuromuscular-junction research. This thought-leadership guide connects its hydroxamate zinc-chelation mechanism, preclinical oncology evidence, and a carefully bounded hypothesis for studying proteolytic BDNF processing.
-
Phytol in RXR Assays: From Mechanism to Workflow
2026-09-11
Phytol and trans-Phytol connect retinoid X receptor signaling with metabolite-aware and GABAergic assay design. This article explains how to translate mechanism into reproducible workflows while using polymer self-assembly research to sharpen solvent and matrix controls.
-
Batimastat (BB-94) for MMP Assay Workflows
2026-09-10
Batimastat (BB-94) provides a broad-spectrum, zinc-targeted approach for separating MMP-dependent matrix remodeling from nonspecific cellular effects. This practical guide connects cell-free enzyme assays, invasion and tumor studies, and emerging neuromuscular-junction applications while emphasizing solvent controls, spatial biology, and mechanism-aware interpretation.
-
Multiple Myeloma Cell Lines: Mutations and Drug Resistance
2026-09-10
This study provides a large-scale exome-based map of mutations across human multiple myeloma cell lines and connects genomic alterations with pathway activity and drug response. Its main practical contribution is a framework for selecting better-characterized models for hematological malignancy research, including studies of progression and resistance.